- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
Psoriasis is a genetic condition that may not be present at birth. The condition may be triggered by certain environmental and genetic factors. Changing lifestyles of people are leading to increased alcohol consumption and smoking, unhealthy diet, and sedentary living, which makes people more prone to this condition.
The global Psoriasis Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Psoriasis Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Psoriasis Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Psoriasis Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
AbbVie
Amgen
Johnson & Johnson
Novartis
Eli Lilly & Company
AstraZeneca
Celgene Corporation
UCB
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tumor Necrosis Factor Inhibitor
Interleukin Inhibitors
Others
Market Segment by Applications, can be divided into
Topicals
Systemic
Biologics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Psoriasis Drugs Market Overview
1.1 Product Overview and Scope of Psoriasis Drugs
1.2 Classification of Psoriasis Drugs by Types
1.2.1 Global Psoriasis Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Psoriasis Drugs Revenue Market Share by Types in 2017
1.2.3 Tumor Necrosis Factor Inhibitor
1.2.4 Interleukin Inhibitors
1.2.5 Others
1.3 Global Psoriasis Drugs Market by Application
1.3.1 Global Psoriasis Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Topicals
1.3.3 Systemic
1.3.4 Biologics
1.4 Global Psoriasis Drugs Market by Regions
1.4.1 Global Psoriasis Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Psoriasis Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Psoriasis Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Psoriasis Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Psoriasis Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Psoriasis Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Psoriasis Drugs (2013-2023)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Psoriasis Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Psoriasis Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Psoriasis Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Psoriasis Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eli Lilly & Company
2.5.1 Business Overview
2.5.2 Psoriasis Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Eli Lilly & Company Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Psoriasis Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Celgene Corporation
2.7.1 Business Overview
2.7.2 Psoriasis Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Celgene Corporation Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 UCB
2.8.1 Business Overview
2.8.2 Psoriasis Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 UCB Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Psoriasis Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global Psoriasis Drugs Market Competition, by Players
3.1 Global Psoriasis Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Psoriasis Drugs Players Market Share
3.2.2 Top 10 Psoriasis Drugs Players Market Share
3.3 Market Competition Trend
4 Global Psoriasis Drugs Market Size by Regions
4.1 Global Psoriasis Drugs Revenue and Market Share by Regions
4.2 North America Psoriasis Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Psoriasis Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Psoriasis Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Psoriasis Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Psoriasis Drugs Revenue and Growth Rate (2013-2018)
5 North America Psoriasis Drugs Revenue by Countries
5.1 North America Psoriasis Drugs Revenue by Countries (2013-2018)
5.2 USA Psoriasis Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Psoriasis Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Psoriasis Drugs Revenue and Growth Rate (2013-2018)
6 Europe Psoriasis Drugs Revenue by Countries
6.1 Europe Psoriasis Drugs Revenue by Countries (2013-2018)
6.2 Germany Psoriasis Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Psoriasis Drugs Revenue and Growth Rate (2013-2018)
6.4 France Psoriasis Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Psoriasis Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Psoriasis Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Psoriasis Drugs Revenue by Countries
7.1 Asia-Pacific Psoriasis Drugs Revenue by Countries (2013-2018)
7.2 China Psoriasis Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Psoriasis Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Psoriasis Drugs Revenue and Growth Rate (2013-2018)
7.5 India Psoriasis Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Psoriasis Drugs Revenue and Growth Rate (2013-2018)
8 South America Psoriasis Drugs Revenue by Countries
8.1 South America Psoriasis Drugs Revenue by Countries (2013-2018)
8.2 Brazil Psoriasis Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Psoriasis Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Psoriasis Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Psoriasis Drugs by Countries
9.1 Middle East and Africa Psoriasis Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Psoriasis Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Psoriasis Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Psoriasis Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Psoriasis Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Psoriasis Drugs Revenue and Growth Rate (2013-2018)
10 Global Psoriasis Drugs Market Segment by Type
10.1 Global Psoriasis Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Psoriasis Drugs Market Forecast by Type (2018-2023)
10.3 Tumor Necrosis Factor Inhibitor Revenue Growth Rate (2013-2023)
10.4 Interleukin Inhibitors Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)
11 Global Psoriasis Drugs Market Segment by Application
11.1 Global Psoriasis Drugs Revenue Market Share by Application (2013-2018)
11.2 Psoriasis Drugs Market Forecast by Application (2018-2023)
11.3 Topicals Revenue Growth (2013-2018)
11.4 Systemic Revenue Growth (2013-2018)
11.5 Biologics Revenue Growth (2013-2018)
12 Global Psoriasis Drugs Market Size Forecast (2018-2023)
12.1 Global Psoriasis Drugs Market Size Forecast (2018-2023)
12.2 Global Psoriasis Drugs Market Forecast by Regions (2018-2023)
12.3 North America Psoriasis Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Psoriasis Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Psoriasis Drugs Revenue Market Forecast (2018-2023)
12.6 South America Psoriasis Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Psoriasis Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Psoriasis Drugs Picture
Table Product Specifications of Psoriasis Drugs
Table Global Psoriasis Drugs and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
